Additional information
| Weight | 0.94 oz |
|---|---|
| Strength | 5mg, 10mg, 20mg, 30mg, 40mg |
GLP-1C
$50.40 – $92.40Price range: $50.40 through $92.40 SAVE 30%
GLP-1S
$29.50 – $49.50Price range: $29.50 through $49.50 SAVE 50%
$54.00 – $304.50Price range: $54.00 through $304.50 SAVE 25–30%
-30%Triple-receptor agonist engaging GLP-1, GIP, and glucagon receptors — the next generation of incretin-based research compounds. Adding glucagon receptor activation targets energy expenditure pathways alongside the appetite and glucose regulation of GLP-1 and GIP. Research areas include metabolic rate and energy balance, hepatic lipid metabolism, body composition, and comparative efficacy with dual-receptor agonists. For research use only — not for human consumption.
Due to recent supply chain and international shipping disruptions, some Batch 002 inventory may include vials produced at different points within our supplier’s production cycle. As a result, researchers may notice minor packaging variations, including differences in vial caps.
These products were sourced from the same established manufacturers we have worked with for ongoing quality and third-party testing. That said, we want to be transparent that Batch 002 may not represent a single uninterrupted production run.
We are already working with our suppliers to strengthen batch-control, packaging, and documentation protocols before Batch 003.
| Weight | 0.94 oz |
|---|---|
| Strength | 5mg, 10mg, 20mg, 30mg, 40mg |
Metabolic Research, Research Bundles
Due to recent supply chain and international shipping disruptions, some Batch 002 inventory may include vials produced at different points within our supplier’s production cycle. As a result, researchers may notice minor packaging variations, including differences in vial caps.
These products were sourced from the same established manufacturers we have worked with for ongoing quality and third-party testing. That said, we want to be transparent that Batch 002 may not represent a single uninterrupted production run.
We are already working with our suppliers to strengthen batch-control, packaging, and documentation protocols before Batch 003.
